163 related articles for article (PubMed ID: 6219026)
1. The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice.
Leiter EH; Beamer WG; Shultz LD
Diabetes; 1983 Feb; 32(2):148-55. PubMed ID: 6219026
[TBL] [Abstract][Full Text] [Related]
2. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus.
Leiter EH
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):630-4. PubMed ID: 6210909
[TBL] [Abstract][Full Text] [Related]
3. Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM.
Baumann EE; Buckingham F; Herold KC
Diabetes; 1995 Aug; 44(8):871-7. PubMed ID: 7621990
[TBL] [Abstract][Full Text] [Related]
4. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.
McEvoy RC; Andersson J; Sandler S; Hellerström C
J Clin Invest; 1984 Sep; 74(3):715-22. PubMed ID: 6088584
[TBL] [Abstract][Full Text] [Related]
5. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
Herold KC; Baumann E; Vezys V; Buckingham F
J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
[TBL] [Abstract][Full Text] [Related]
6. Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings.
Cossel L; Schneider E; Kuttler B; Schmidt S; Wohlrab F; Schade J; Bochmann C
Exp Clin Endocrinol; 1985 Feb; 85(1):7-26. PubMed ID: 3157595
[TBL] [Abstract][Full Text] [Related]
7. L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice.
Kantwerk G; Cobbold S; Waldmann H; Kolb H
Clin Exp Immunol; 1987 Dec; 70(3):585-92. PubMed ID: 2963718
[TBL] [Abstract][Full Text] [Related]
8. Analyses of development of insulitogenic T lymphocytes in NOD mice by transplantation of bone marrow, thymus, and pancreas.
Ida T; Yasumizu R; Ohnishi Y; Honxue F; Oyaizu N; Than S; Sugiura K; Inaba MM; Kuzuya H; Makino S
Transplantation; 1990 May; 49(5):976-82. PubMed ID: 2186525
[TBL] [Abstract][Full Text] [Related]
9. Effects of cyclosporin on autoimmune diabetes induced in mice by streptozotocin: beta cell-toxicity and rebound of insulitis after cessation of treatment.
Sai P; Maugendre D; Loreal O; Maurel C; Pogu S
Diabete Metab; 1988; 14(4):455-62. PubMed ID: 3066654
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin.
Fraser RB; Rowden G; Colp P; Wright JR
Diabetologia; 1997 Nov; 40(11):1263-8. PubMed ID: 9389417
[TBL] [Abstract][Full Text] [Related]
11. The diabetogenic effects of streptozotocin in mice are prolonged and inversely related to age.
Riley WJ; McConnell TJ; Maclaren NK; McLaughlin JV; Taylor G
Diabetes; 1981 Sep; 30(9):718-23. PubMed ID: 6455320
[TBL] [Abstract][Full Text] [Related]
12. Induction of tolerance to autoimmune diabetes with islet antigens.
Herold KC; Montag AG; Buckingham F
J Exp Med; 1992 Oct; 176(4):1107-14. PubMed ID: 1402656
[TBL] [Abstract][Full Text] [Related]
13. Auto-reconstitution of the T-cell compartment by radioresistant hematopoietic cells following lethal irradiation and bone marrow transplantation.
Bosco N; Swee LK; Bénard A; Ceredig R; Rolink A
Exp Hematol; 2010 Mar; 38(3):222-232.e2. PubMed ID: 20045443
[TBL] [Abstract][Full Text] [Related]
14. Early manifestations in multiple-low-dose streptozotocin-induced diabetes in mice.
Karabatas LM; Pastorale C; de Bruno LF; Maschi F; Pivetta OH; Lombardo YB; Chemes H; Basabe JC
Pancreas; 2005 May; 30(4):318-24. PubMed ID: 15841040
[TBL] [Abstract][Full Text] [Related]
15. Modulation of streptozotocin-induced insulitis and hyperglycaemia in the mouse.
Sandler S; Andersson A
Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):93-8. PubMed ID: 3157292
[TBL] [Abstract][Full Text] [Related]
16. Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent.
Pechhold K; Patterson NB; Blum C; Fleischacker CL; Boehm BO; Harlan DM
J Immunol; 2001 Feb; 166(4):2531-9. PubMed ID: 11160314
[TBL] [Abstract][Full Text] [Related]
17. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells.
Herold KC; Bloch TN; Vezys V; Sun Q
Diabetes; 1995 Mar; 44(3):354-9. PubMed ID: 7883124
[TBL] [Abstract][Full Text] [Related]
18. Morphologic-histochemical characterization of inflammatory cells in insulitis induced by multiple subdiabetogenic doses of streptozotocin in C57B1/KsJ mice.
Schneider E; Wohlrab F; Cossel L
Biomed Biochim Acta; 1984; 43(5):683-90. PubMed ID: 6236802
[TBL] [Abstract][Full Text] [Related]
19. Low dose streptozotocin causes diabetes in severe combined immunodeficient (SCID) mice without immune cell infiltration of the pancreatic islets.
Reddy S; Wu D; Elliott RB
Autoimmunity; 1995; 20(2):83-92. PubMed ID: 7578872
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes.
Mueller R; Lee MS; Sawyer SP; Sarvetnick N
J Autoimmun; 1996 Apr; 9(2):151-8. PubMed ID: 8738958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
